Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving patient selection for clinical acute stroke trials.

Christian Weimar1, Tony W Ho, Zaza Katsarava

  • 1Department of Neurology, University of Essen, Essen, Germany.

Cerebrovascular Diseases (Basel, Switzerland)
|February 24, 2006
PubMed
Summary

Optimizing acute stroke trial inclusion criteria using prognostic models can reduce trial time and size. This approach enhances enrollment speed and treatment effect for better stroke research outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contemporary achievement of guideline recommendations for blood pressure management after stroke in the CONVINCE trial.

European stroke journal·2026
Same author

The Course of Rehabilitation of Ventilated and Tracheally Cannulated Patients in Neurological-Neurosurgical Early Rehabilitation.

Deutsches Arzteblatt international·2026
Same author

Validation of the SMART-REACH model after stroke and the effect of colchicine by atherosclerotic cardiovascular disease risk category: a secondary analysis of the CONVINCE randomised clinical trial.

European stroke journal·2026
Same author

Guidelines for Neuroprognostication in Critically ill Adults with Acute Ischemic Stroke.

Neurocritical care·2026
Same author

Guidelines for Neuroprognostication in Critically Ill Adults with Status Epilepticus.

Neurocritical care·2026
Same author

Public Health.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Area of Science:

  • Neurology
  • Clinical Trials
  • Biostatistics

Background:

  • Acute ischemic stroke clinical trials require precise patient selection for efficiency.
  • Current inclusion criteria, often based solely on the National Institutes of Health Stroke Scale (NIH-SS), may not fully optimize trial resources.
  • Predicting patient outcomes is crucial for designing effective clinical studies.

Purpose of the Study:

  • To develop and validate an optimized method for selecting patient inclusion criteria in acute stroke clinical trials.
  • To improve the efficiency of clinical trials by reducing trial time and study size.
  • To identify potential treatment responders more accurately.

Main Methods:

  • Stratified prognostic models were developed using age and NIH-SS scores to predict death and complete recovery.

Related Experiment Videos

  • Computer simulations were performed on an independent dataset of 1,725 acute ischemic stroke patients.
  • Various inclusion thresholds were tested to calculate the number and percentage of potential treatment responders.

    • Main Results:

    • Defined thresholds for recovery and mortality significantly decreased trial time and study size compared to fixed NIH-SS criteria.
    • The use of prognostic models allows for optimization of either trial time or study size.
    • Simulations demonstrated a more efficient selection of patients likely to benefit from treatment.

    Conclusions:

    • Validated models enable efficient study inclusion of potential treatment responders based on the Barthel Index at 100 days post-stroke.
    • These techniques offer improved stroke trial enrollment speed, treatment effect size, or both.
    • The approach provides a pathway for more effective and resource-efficient acute stroke research.